436 results on '"Creutzberg, Carien"'
Search Results
2. Sexual health—a topic for cancer patients receiving oncological treatment with palliative intent
3. Effect of reduced follow-up care on patient satisfaction with care among patients with endometrial cancer: The ENSURE randomized controlled trial
4. Clinical research in endometrial cancer: consensus recommendations from the Gynecologic Cancer InterGroup
5. MR-based follow-up after brachytherapy and proton beam therapy in uveal melanoma
6. International Federation of Gynecology and Obstetrics Endometrial 2023 Is Better For Radiation Oncology Patients
7. Prognostic impact and causality of age on oncological outcomes in women with endometrial cancer: a multimethod analysis of the randomised PORTEC-1, PORTEC-2, and PORTEC-3 trials
8. 2023 FIGO staging system for endometrial cancer: The evolution of the revolution
9. Predictive Factors for Toxicity After Primary Chemoradiation for Locally Advanced Cervical Cancer: A Systematic Review
10. Molecular and Clinicopathologic Characterization of Mismatch Repair-Deficient Endometrial Carcinoma Not Related to MLH1 Promoter Hypermethylation
11. Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistry
12. International validation of a health-related quality-of-life questionnaire for Hodgkin lymphoma: the EORTC QLQ-HL27
13. Interpretable deep learning model to predict the molecular classification of endometrial cancer from haematoxylin and eosin-stained whole-slide images: a combined analysis of the PORTEC randomised trials and clinical cohorts
14. p53 immunohistochemistry in endometrial cancer: clinical and molecular correlates in the PORTEC-3 trial
15. Automated causal inference in application to randomized controlled clinical trials
16. Tertiary lymphoid structures critical for prognosis in endometrial cancer patients
17. Radiation Therapy Techniques and Treatment-Related Toxicity in the PORTEC-3 Trial: Comparison of 3-Dimensional Conformal Radiation Therapy Versus Intensity-Modulated Radiation Therapy
18. Clinical research in endometrial cancer: consensus recommendations from the Gynecologic Cancer InterGroup.
19. Psychometric validation of the European Organisation for Research and Treatment of Cancer–Quality of Life Questionnaire Sexual Health (EORTC QLQ-SH22)
20. Patients' and clinicians' preferences in adjuvant treatment for high-risk endometrial cancer: Implications for shared decision making
21. Long-Term Toxicity and Health-Related Quality of Life After Adjuvant Chemoradiation Therapy or Radiation Therapy Alone for High-Risk Endometrial Cancer in the Randomized PORTEC-3 Trial
22. NRG Oncology/RTOG Consensus Guidelines for Delineation of Clinical Target Volume for Intensity Modulated Pelvic Radiation Therapy in Postoperative Treatment of Endometrial and Cervical Cancer: An Update
23. Vulvar cancer subclassification by HPV and p53 status results in three clinically distinct subtypes
24. ESGO/ESTRO/ESP Guidelines for the management of patients with endometrial carcinoma
25. Management of conjunctival melanoma with local excision and adjuvant brachytherapy
26. PARP and PD-1/PD-L1 checkpoint inhibition in recurrent or metastatic endometrial cancer
27. An international update of the EORTC questionnaire for assessing quality of life in breast cancer patients: EORTC QLQ-BR45
28. A sexual rehabilitation intervention for women with gynaecological cancer receiving radiotherapy (SPARC study): design of a multicentre randomized controlled trial
29. Accuracy, repeatability, and reproducibility of water-fat magnetic resonance imaging in a phantom and healthy volunteer
30. Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial
31. Refinement of high-risk endometrial cancer classification using DNA damage response biomarkers: a TransPORTEC initiative
32. International development of four EORTC disease-specific quality of life questionnaires for patients with Hodgkin lymphoma, high-and low-grade non-Hodgkin lymphoma and chronic lymphocytic leukaemia
33. 3408: Ten-year results of the PORTEC-3 trial: adjuvant therapy for women with high-risk endometrial cancer
34. 1857: Ruthenium-106 brachytherapy for uveal melanoma: impact of dose deviations
35. 1681: Intuitively customizable AI-based cervix brachytherapy treatment planning
36. 919: Randomised trial of nurse-led sexual rehabilitation after radiotherapy for gynaecological cancers
37. Response: FIGO staging of endometrial cancer 2023.
38. Time Trends in the Treatment and Survival of 5036 Uveal Melanoma Patients in The Netherlands over a 30-Year Period.
39. Ruthenium-106 brachytherapy for choroidal melanoma without transpupillary thermotherapy: Similar efficacy with improved visual outcome
40. International development of four EORTC disease-specific quality of life questionnaires for patients with Hodgkin lymphoma, high- and low-grade non-Hodgkin lymphoma and chronic lymphocytic leukaemia
41. Radiation therapy combined with hyperthermia versus cisplatin for locally advanced cervical cancer: Results of the randomized RADCHOC trial
42. Toxicity and quality of life after adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): an open-label, multicentre, randomised, phase 3 trial
43. Endometrial cancer
44. Prognostic significance of L1CAM expression and its association with mutant p53 expression in high-risk endometrial cancer
45. Groin surgery and risk of recurrence in lymph node positive patients with vulvar squamous cell carcinoma
46. Long-Term Impact of Endometrial Cancer Diagnosis and Treatment on Health-Related Quality of Life and Cancer Survivorship: Results From the Randomized PORTEC-2 Trial
47. Variability in clinical target volume delineation for intensity modulated radiation therapy in 3 challenging cervix cancer scenarios
48. Selecting Adjuvant Treatment for Endometrial Carcinoma Using Molecular Risk Factors
49. Molecular Classification Predicts Response to Radiotherapy in the Randomized PORTEC-1 and PORTEC-2 Trials for Early-Stage Endometrioid Endometrial Cancer.
50. FIGO staging of endometrial cancer: 2023.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.